IRIS
OTTANA', Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.941
NA - Nord America 6.718
AS - Asia 3.911
SA - Sud America 1.553
AF - Africa 101
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.589
RU - Federazione Russa 4.036
SG - Singapore 1.687
BR - Brasile 1.334
CN - Cina 1.100
IE - Irlanda 1.051
SE - Svezia 954
HK - Hong Kong 448
DE - Germania 403
UA - Ucraina 395
IT - Italia 272
FI - Finlandia 221
FR - Francia 219
VN - Vietnam 198
GB - Regno Unito 161
IN - India 104
PL - Polonia 77
AR - Argentina 61
CA - Canada 54
BD - Bangladesh 48
IQ - Iraq 43
EC - Ecuador 41
MX - Messico 40
TR - Turchia 36
JP - Giappone 33
CO - Colombia 30
AT - Austria 29
MA - Marocco 28
UZ - Uzbekistan 27
PK - Pakistan 26
VE - Venezuela 26
IR - Iran 21
NL - Olanda 21
ZA - Sudafrica 21
ID - Indonesia 20
BE - Belgio 17
CL - Cile 16
CZ - Repubblica Ceca 15
KE - Kenya 15
PY - Paraguay 13
JM - Giamaica 12
BO - Bolivia 11
KR - Corea 11
UY - Uruguay 11
JO - Giordania 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
DZ - Algeria 9
IL - Israele 9
PE - Perù 9
ES - Italia 8
LT - Lituania 8
NP - Nepal 8
RS - Serbia 8
AU - Australia 7
EG - Egitto 7
GR - Grecia 7
MY - Malesia 7
PH - Filippine 7
TN - Tunisia 7
CH - Svizzera 6
KZ - Kazakistan 6
LV - Lettonia 6
NO - Norvegia 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
PT - Portogallo 5
LB - Libano 4
TT - Trinidad e Tobago 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
LK - Sri Lanka 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
HR - Croazia 2
KW - Kuwait 2
MM - Myanmar 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
BW - Botswana 1
CU - Cuba 1
EE - Estonia 1
GE - Georgia 1
Totale 20.221
Salva come PNG Salva come JPEG
Città #
Moscow 1.259
Dublin 1.050
Singapore 896
Jacksonville 783
Ashburn 767
Chandler 712
Dallas 701
Nyköping 594
Hong Kong 446
Dearborn 434
Beijing 378
San Jose 243
The Dalles 191
Princeton 181
Medford 176
Cambridge 172
Lauterbourg 154
Los Angeles 151
Des Moines 97
Ann Arbor 94
Boardman 93
Buffalo 89
Ho Chi Minh City 86
São Paulo 85
Munich 83
Warsaw 72
New York 71
Messina 64
San Mateo 61
Council Bluffs 58
Tianjin 56
Jinan 49
Belo Horizonte 46
Wilmington 46
Guangzhou 44
Turku 39
Rio de Janeiro 38
Woodbridge 33
Orem 27
Santa Clara 27
Chennai 26
Hanoi 26
Vienna 26
Lancaster 25
Curitiba 24
Redondo Beach 24
Shenyang 24
Tokyo 24
Haikou 23
Nanjing 23
Frankfurt am Main 22
Tashkent 22
Seattle 21
Shanghai 21
Brasília 20
Denver 20
Phoenix 19
Salvador 19
Baghdad 18
Brussels 17
Houston 17
Atlanta 16
Campinas 16
Hebei 16
St Petersburg 16
Ardabil 15
Chicago 15
Milan 15
Shenzhen 15
Montreal 14
Johannesburg 13
London 13
Ningbo 13
Quito 13
Stockholm 13
Brooklyn 12
Fuzhou 12
San Francisco 12
Taiyuan 12
Taizhou 12
Washington 12
Boston 11
Dhaka 11
Düsseldorf 11
Hefei 11
Manchester 11
Nanchang 11
Porto Alegre 11
Pune 11
Francofonte 10
Istanbul 10
Manaus 10
Mexico City 10
Mumbai 10
Nairobi 10
Pelotas 10
Sorocaba 10
Windsor 10
Augusta 9
Bremen 9
Totale 11.578
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 252
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 208
Synthesis of tertiary alkyl-substituted acetylenes by electrophilic addition to silylacetylenes 201
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 188
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 188
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 187
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 183
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 183
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 182
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 177
3,3'-bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanediyl) derivatives and corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity 176
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 175
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 175
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 174
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 174
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 172
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 170
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 169
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 166
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 166
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 165
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 164
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 163
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 163
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 162
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 160
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 158
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 158
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 158
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 157
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 156
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 156
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 155
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 151
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 151
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 150
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 148
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 148
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 147
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 146
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 146
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 146
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 145
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 145
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 144
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 142
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 141
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 140
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 139
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 139
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 138
HALOGENATED ISONIAZID DERIVATIVES .2. UNUSUAL SYNTHESIS OF DELTA(2)-1,3,4-OXADIAZOLINE DERIVATIVES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 136
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 136
Electronegativity of zeolites in relation to catalytic activity in the conversion of methanol to hydrocarbons 133
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 133
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 132
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 131
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 131
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 130
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 127
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 127
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 126
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 125
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 124
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 124
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 122
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 122
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 121
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 121
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 121
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 118
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 117
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 117
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 117
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 116
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 115
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 115
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 114
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 113
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 112
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 109
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 108
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 107
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 106
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 106
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 105
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 105
Utilization of zeolites in agriculture. Part II: Influence in spinach growing. 105
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 105
Sintesi di idrocarburi da metanolo su zeoliti commerciali. Relazione fra attività catalitica e acidità 105
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 104
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 103
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 103
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 103
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 102
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 102
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 102
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 102
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 101
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 101
Totale 14.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.495
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/20221.073 6 136 34 42 61 5 72 43 13 106 168 387
2022/20232.957 234 285 143 263 198 312 68 129 1.219 13 64 29
2023/2024514 37 94 75 41 57 96 7 27 0 15 6 59
2024/20253.128 62 25 52 167 140 71 59 712 838 187 234 581
2025/20269.241 389 677 716 795 655 2.142 1.134 1.121 1.020 331 180 81
Totale 20.329